On one hand, they reported that atrial arrhythmia (atrial fibrillation/atrial flutter) is most common in patients with (L.)pathogenic variants affecting FBN1 compared to patients with (L.)pathogenic variants in other TGF-β signaling genes. The gene discussed is TGFB1; the disease is atrial flutter.